Valuation: Vineet Laboratories Limited

Market Cap 558M 5.83M 5.12M 4.78M 4.39M 8.21M 8.41M 56.67M 22.16M 276M 21.88M 21.4M 955M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 9.98M 8.77M 8.18M 7.51M 14.06M 14.4M 97.03M 37.94M 473M 37.45M 36.64M 1.63B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
22/07 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
29/05 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
14/02 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/02 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
17/12 Vineet Laboratories says rights issue price set at 30 rupees per share RE
27/11 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
27/11 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
24/11 Vineet Laboratories to consider rights issue RE
08/11 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
17/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
13/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/11/24 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day+0.75%
1 week+3.13%
Current month+15.97%
1 month+15.32%
3 months+7.60%
6 months+17.29%
Current year+6.61%
1 week 35.65
Extreme 35.65
40
1 month 31.5
Extreme 31.5
40
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
114.9
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 56 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+3.13%+28.10%-22.36% 7.82M
-0.20%+4.93%+59.95%+168.47% 1,089B
+0.19%+4.51%+58.93%+59.48% 643B
+1.15%+5.21%+39.37%+78.17% 465B
-1.69%+8.81%+39.38%+33.67% 359B
-0.51%+3.51%+36.97%+42.46% 303B
+1.50%+3.40%+17.71%+17.41% 267B
+0.79%+5.81%-2.55%-38.10% 226B
-0.74%+6.52%+28.44%+66.52% 212B
-0.12%+2.98%+17.50%+76.28% 167B
Average +0.11%+4.80%+32.38%+48.20% 373.11B
Weighted average by Cap. +0.02%+5.14%+42.86%+81.96%

Financials

2024 2025
Net sales 1.51K 15.76 13.85 12.93 11.86 22.21 22.76 153.29 59.95 747.03 59.17 57.89 2.58K 769.53 8.03 7.06 6.59 6.05 11.32 11.6 78.14 30.56 380.79 30.16 29.51 1.32K
Net income 10.27M 107K 94.22K 87.95K 80.72K 151K 155K 1.04M 408K 5.08M 403K 394K 17.57M -202M -2.11M -1.85M -1.73M -1.59M -2.97M -3.04M -20.5M -8.02M -99.91M -7.91M -7.74M -345M
Net Debt 441M 4.6M 4.04M 3.77M 3.46M 6.48M 6.64M 44.75M 17.5M 218M 17.28M 16.9M 754M 397M 4.15M 3.65M 3.4M 3.12M 5.85M 5.99M 40.35M 15.78M 197M 15.58M 15.24M 680M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
29/07/26 INR 39.21 +0.75% 74,565
28/07/26 INR 38.92 +0.13% 23,066
27/07/26 INR 38.87 +0.91% 49,004
24/07/26 INR 38.52 +2.99% 73,138
23/07/26 INR 37.40 +0.19% 50,064
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock